The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
Keywords: کیناز پروتئین فعال Mitogen; cancer; Hippo; eye; intraocular; YAP; Oct4; VP; Verteporfin; RB; Retinoblastoma; MTT; (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide); PDT; Photodynamic therapy; MAPK; Mitogen-activated protein kinases; Vgll; Vestigial-like (Vgll);